| Name | Title | Contact Details |
|---|
BPM+ Health™ is a community initiative to improve the quality and consistency of healthcare delivery. It will achieve this by applying business process modeling standards to clinical best practices, care pathways and workflows directly at the point of care. It is a cross-discipline group of professional organizations, clinical societies, and healthcare providers working together to develop and pilot standards-driven healthcare process automation techniques to fully realize the benefits of Healthcare IT. Founding Members: American College of Emergency Physicians (ACEP), Auxilium Technology Group, EvidenceCare, Mayo Clinic, MDIX, Perspecta, Red Hat, Trisotech, University of Utah, University of Washington, U.S. Department of Veterans Affairs Industry Supporters: HIMSS, HL7, HSPC, NCQA, AHRQ BPM+ Health is a program of the Object Management Group® (OMG®).
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
Health One is a Ridgeland, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ga Assoc For Primary Health Care is a Decatur, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Osmotica Pharmaceutical is a global specialty pharmaceutical company with a proven history of developing commercially successful pharmaceutical products. The company uses its proprietary osmotic technology platform and with strategic partners develops and commercializes high quality pharmaceutical products. In addition to the products currently on the market, the company’s pipeline includes numerous ANDA programs and several innovative neurology-based NDA programs. Osmotica Pharmaceutical and its related companies form an international group of companies with principal operations located in the United States, Argentina and Hungary.